We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




LAMP Assay Developed for Trichomoniasis

By LabMedica International staff writers
Posted on 26 Aug 2014
Print article
Image: Scanning electron micrograph of a Trichomonas vaginalis trophozoite (Photo courtesy of Dr. Dennis Kunkel).
Image: Scanning electron micrograph of a Trichomonas vaginalis trophozoite (Photo courtesy of Dr. Dennis Kunkel).
A loop-mediated isothermal amplification (LAMP) assay targeting a repeated DNA species-specific sequence was developed for detection of Trichomonas vaginalis, the causative agent of trichomoniasis.

The most common laboratory diagnostic tests for T. vaginalis infections include wet-mount microscopy; culture; and, recently, nucleic acid amplification tests (NAATs) using genital swab, urine, or semen samples. Culture is the gold standard for diagnosis of T. vaginalis, although its sensitivity can be as low as microscopy, and requires at least a week of incubation and daily microscopy for optimal performance.

Parasitologists at the University of the Philippines (Manila, Philippines) collected a total of 16 genital swabs and two urine specimens were from women attending a Reproductive Health and Wellness Center. Mid-log-phase axenic T. vaginalis cultures (107 trichomonads/mL) and 1 mL aliquot of clinical specimens were pelleted by centrifugation. All specimens were examined for the presence of T. vaginalis by polymerase chain reaction (PCR).

LAMP primers specific for T. vaginalis were designed based on the highly repeated two kilo-base pair (2-Kbp) DNA fragment of T. vaginalis. The LAMP products were assessed by gel electrophoresis, assessment of turbidity, and addition of SYBR Safe DNA Gel Stain (Invitrogen, Carlsbad, CA, USA) and visualized under an ultra-violet UV transilluminator (UVP; Upland, CA, USA). An orange-to-pink color change under natural light or a dull to fluorescent signal under UV transilluminator indicated a positive reaction.

Of the 16 genital swab specimens, 15 were negative by PCR, and the two urine specimens were also negative. All negative samples were pooled and used for spiking in the analytical sensitivity evaluation. In spiked genital swab samples, the results indicate that the detection limit of the LAMP method was 100 trichomonads/mL or one trichomonad either by gel electrophoresis, turbidity, or addition of SYBR Safe, while the detection limit of PCR was 103 trichomonads/mL or 1,000 trichomonads. The T. vaginalis LAMP exhibited no cross-reactivity with DNA extracts from closely-related trichomonads, Trichomonas tenax and Pentatrichomonas hominis, and other enteric and urogenital microorganisms, Entamoeba histolytica, Candida albicans, Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus.

The authors concluded that the T. vaginalis LAMP assay developed was simple, rapid, sensitive, and specific method for the detection of trichomoniasis, the most common curable sexually transmitted infection. This efficient and cost-effective NAAT has a great potential application for accurate diagnosis and large-scale surveillance, screening, and control of trichomoniasis in point-of-care and resource-limited settings. The study was published in the July 2014 issue of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

University of the Philippines
Invitrogen
UVP


New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Uric Acid and Blood Glucose Meter
URIT-10
New
Silver Member
HPV Molecular Controls
ZeptoMetrix® HPV Type 16, 18, 45 & 68 Molecular Controls

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.